chlorambucil news

All news on chlorambucil (also known as Leukeran and 4-[4-(bis(2-chloroethyl)amino)phenyl]butanoic acid): plants, production capacities, investments and involved companies.

20 April 2026

FDA Accepts Genentech sBLA for Gazyva in SLE

FDA accepted sBLA for an anti‑CD20 in SLE after Phase III ALLEGORY: SRI‑4 responders 76.7% vs 53.5%, higher remission, fewer flares and steroid reduction; decision due Dec 2026.

Who will be producing chlorambucil in the future?

Find out with chemXplore Alpha

Learn more